Abstract
KLF2 is a member of the Kruppel-like transcription factor family of proteins containing highly conserved DNA-binding zinc finger domains. KLF2 participates in the differentiation and regulation of the functional activity of monocytes, T lymphocytes, adipocytes, and vascular endothelial cells. The activity of KLF2 is controlled by several regulatory systems, including the MEKK2,3/MEK5/ERK5/MEF2 MAP kinase cascade, Rho family G-proteins, histone acetyltransferases CBP and p300, and histone deacetylases HDAC4 and HDAC5. Activation of KLF2 in endothelial cells induces eNOS expression and provides vasodilatory effect. Many KLF2-dependent genes participate in the suppression of blood coagulation and aggregation of T cells and macrophages with the vascular endothelium, thereby preventing atherosclerosis progression. KLF2 can have a dual effect on the gene transcription. Thus, it induces expression of multiple genes, but suppresses transcription of NF-KB-dependent genes. Transcription factors KLF2 and NF-KB are reciprocal antagonists. KLF2 inhibits induction of NF-KB-dependent genes, whereas NF-KB downregulates KLF2 expression. KLF2-mediated inhibition of NF-KB signaling leads to the suppression of cell response to the pro-inflammatory cytokines IL-ip and TNFa and results in the attenuation of inflammatory processes.
Similar content being viewed by others
Abbreviations
- AMPK:
-
AMP-dependent protein kinase
- CaMK:
-
calcium/calmodulin-dependent protein kinase
- eNOS:
-
endothelial nitric oxide synthase
- ERK5:
-
extracellular signal-regulated kinase 5
- HDAC:
-
histone deacetylase
- HO-1:
-
heme oxygenase-1
- ICAM-1:
-
intercellular adhesion molecule-1
- KLF:
-
Kruppel-like factor
- MAPK:
-
mitogen-activated protein kinase
- MEF2:
-
myocyte enhancer factor 2
- MEK5:
-
MAP kinase kinase 5
- MEKK:
-
MAP kinase kinase kinase
- PECAM-1:
-
platelet/endothelial cell adhesion molecule-1
- VCAM-1:
-
vascular cell adhesion molecule-1
- VEGF(R):
-
vascular endothelial growth factor (receptor).
References
Miller, I. J., and Bieker, J. J. (1993) A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Kriippel family of nuclear proteins, Mol. Cell Biol., 13, 2776–2786.
Pei, J., and Grishin, N. V. (2015) C2H2 zinc finger proteins of the SP/KLF, Wilms tumor, EGR, Huckebein, and BIOCHEMISTRY (Moscow) Vol. 85 No. 1 2020 Klumpfuss families in metazoans and beyond, Gene, 573, 91–99.
Pollak, N. M., Hoffman, M., Goldberg, I. J., and Drosatos, K. (2018) Kriippel-like factors: crippling and un-crippling metabolic pathways, JACC Basic Transl. Sci., 3, 132–156.
Lomberk, G., and Urrutia, R. (2005) The family feud: turning off Spl by Sp 1-like KLF proteins, Biochem. J., 392, 1–11.
Stubbs, L., Sun, Y., and Caetano-Anolles, D. (2011) Function and evolution of C2H2 zinc finger arrays, Subcell. Biochem., 52, 75–94.
Bialkowska, A. B., Yang, V. W., and Mallipattu, S. K. (2017) Kriippel-like factors in mammalian stem cells and development, Development, 144, 737–754.
Pearson, R., Fleetwood, J., Eaton, S., Crossley M., and Bao, S. (2008) Kriippel-like transcription factors: a functional family, Int. J. Biochem. Cell Biol., 40, 1996–2001.
Kaczynski, J., Cook, T., and Urrutia, R. (2003) Sp1 - and Kriippel-like transcription factors, Genome Biol., 4, 206.
Wu, Z., and Wang, S. (2013) Role of Kriippel-like transcription factors in adipogenesis, Dev. Biol., 373, 235–243.
Zhang, P., Basu, P., Redmond, L. C., Morris, P. E., Rupon, J. W., Ginder, G. D., and Lloyd, J. A. (2005) A functional screen for Kriippel-like factors that regulate the human gamma-globin gene through the CACCC promoter element, Blood Cells Mol. Dis., 35, 227–235.
Huang, B., Ami, Y. T., McPherson, L., Clayberger, C., and Krensky A. M. (2007) Interaction of PRP4 with Kruppel-like factor 13 regulates CCL5 transcription, J. Immunol., 178, 7081–7087.
Kaczynski, J. A., Conley A. A., Fernandez Zapico, M., Delgado, S. M., Zhang, J. S., and Urrutia, R. (2002) Functional analysis of basic transcription element (BTE)-binding protein (BTEB) 3 and BTEB4, a novel Spl-like protein, reveals a subfamily of transcriptional repressors for the BTE site of the cytochrome P4501A1 gene promoter, Biochem. J., 366, 873–882.
Mas, C., Lussier-Price, M., Soni, S., Morse, T., Arseneault, G., Di Lello, P., Lafrance-Vanasse, J., Bieker, J. J., and Omichinski, J. G. (2011) Structural and functional characterization of an atypical activation domain in erythroid Kruppel-like factor (EKLF), Proc. Natl. Acad. Sci. USA, 108, 10484–10489.
Presnell, J. S., Schnitzler, C. E., and Browne, W. E. (2015) KLF/SP transcription factor family evolution: expansion, diversification, and innovation in eukaryotes, Genome Biol. Evol., 7, 2289–2309.
Schmitz, M. L., and de la Vega, L. (2015) New insight into the role of histone deacetylases as coactivators of inflammatory gene expression, Antioxid. Redox Signal., 23, 85–98.
Wagner, T., Brand, P., Heinzel, T., and Kramer, O. H. (2014) Histone deacetylase 2 controls p53 and is a critical factor in tumorigenesis, Biochim. Biophys. Acta, 1846, 524–538.
Anderson, K. P., Kern, C. B., Crable, S. C., and Lingrel, J. B. (1995) Isolation of a gene encoding a functional zinc finger protein homologous to erythroid Kriippel-like factor: identification of a new multigene family, Mol. Cell Biol., 15, 5957–5965.
Novodvorsky P., and Chico, T. J. (2014) The role of the transcription factor KLF2 in vascular development and disease, Prog. Mol. Biol. Transl. Sci., 124, 155–188.
Jha, P., and Das, H. (2017) KLF2 in regulation of NF-KB-mediated immune cell function and inflammation, Int. J. Mol. Sci., 18, E2383.
Ghaleb, A. M., and Yang, V. W. (2017) Kriippel-like factor 4 (KLF4): what we currently know, Gene, 611, 27–37.
Chestkov, I. V., Khomyakova, E. A., Vasilieva, E. A., Lagarkova, M. A., and Kiselev, S. L. (2014) Molecular barriers to processes of genetic reprogramming and cell transformation, Biochemistry (Moscow), 79, 1297–1307.
Kunes, P., Holubcova, Z., and Krejsek, J. (2009) Occurrence and significance of the nuclear transcription factor Kriippel-like factor 4 (KLF4) in the vessel wall, Acta Medica (Hradec Kralove), 52, 135–139.
Villarreal, G., Jr., Zhang, Y., Larman, H. B., Gracia-Sancho, J., Koo, A., and Garcia-Cardena, G. (2010) Defining the regulation of KLF4 expression and its downstream transcriptional targets in vascular endothelial cells, Biochem. Biophys. Res. Commun., 391, 984–989.
Zhao, Y., and Sun, Y. (2013) The FBW7-KLF2 axis regulates endothelial functions, Cell Res., 23, 741–743.
Zhang, X., Srinivasan, S. V., and Lingrel, J. B. (2004) WWP1-dependent ubiquitination and degradation of the lung Kriippel-like factor, KLF2, Biochem. Biophys. Res. Commun., 316, 139–148.
Sohn, S. J., Li, D., Lee, L. K., and Wmoto, A. (2005) Transcriptional regulation of tissue-specific genes by the ERK5 mitogen-activated protein kinase, Mol. Cell Biol., 25, 8553–8566.
Chen, X., Gao, B., Ponnusamy M., Lin, Z., and Liu, J. (2017) MEF2 signaling and human diseases, Oncotarget, 8, 112152–112165.
Roberts, O. L., Holmes, K., Muller, J., Cross, D. A., and Cross, M. J. (2009) ERK5 and the regulation of endothelial cell function, Biochem. Soc. Trans., 37, 1254–1259.
Drew, B. A., Burow, M. E., and Beckman, B. S. (2012) MEK5/ERK5 pathway: the first fifteen years, Biochim. Biophys. Acta, 1825, 37048.
Nakajima, H., and Mochizuki, N. (2017) Flow pattern-dependent endothelial cell responses through transcriptional regulation, Cell Cycle, 16, 1893–1901.
Nigro, P., Abe, J., and Berk, B. C. (2011) Flow shear stress and atherosclerosis: a matter of site specificity, Antioxid. Redox Signal., 15, 1405–1414.
Simmons, R. D., Kumar, S., and Jo, H. (2016) The role of endothelial mechanosensitive genes in atherosclerosis and omics approaches, Arch. Biochem. Biophys., 591, 111–131.
Lu, L., Huang, W., Hu, W., Jiang, L., Li, Y., Wu, X., Yuan, D., and Li, M. (2019) Kruppel-like factor 2 mediated anti-prolif-erative and anti-metastasis effects of simvastatin in p53 mutant colon cancer, Biochem. Biophys. Res. Commun., 511, 772–779.
Heo, K. S., Berk, B. C., and Abe, J. (2016) Disturbed flow-induced endothelial proatherogenic signaling via regulating post-translational modifications and epigenetic events, Antioxid. Redox Signal., 25, 435–450.
Ballermann, B. J., Dardik, A., Eng, E., and Liu, A. (1998) Shear stress and the endothelium, Kidney Int. Suppl., 67, S100-108.
Givens, C., and Tzima, E. (2016) Endothelial mechanosig-naling: does one sensor fit all? Antioxid. Redox Signal., 25, 373–388.
Liu, H. B., Zhang, J., Xin, S. Y., Liu, C., Wang, C. Y., Zhao, D., and Zhang, Z. R. (2013) Mechanosensitive properties in the endothelium and their roles in the regulation of endothelial function, J. Cardiovasc. Pharmacol, 61, 461–470.
Ando, J., and Yamamoto, K. (2013) Flow detection and calcium signaling in vascular endothelial cells, Cardiovasc. Res., 99, 260–268.
Snyder, J. L., McBeath, E., Thomas, T. N., Chiu, Y. J., Clark, R. L., and Fujiwara, K. (2017) Mechanotransduction properties of the cytoplasmic tail of PECAM-1, Biol. Cell, 109, 312–321.
Conway, D. E., Coon, B. G., Budatha, M., Arsenovic, P. T, Orsenigo, F., Wessel, F., Zhang, J., Zhuang, Z., Dejana, E., Vestweber, D., and Schwartz, M. A. (2017) VE-cadherin phosphorylation regulates endothelial fluid shear stress responses through the polarity protein LGN, Curr. Biol., 11, 2219–2225.
Kwon, I. S., Wang, W., Xu, S., and Jin, Z. G. (2014) Histone deacetylase 5 interacts with Kruppel-like factor 2 and inhibits its transcriptional activity in endothelium, Cardiovasc. Res., 104, 127–137.
McSweeney S. R., Warabi, E., and Siow, R. C. (2016) Nrf2 as an endothelial mechanosensitive transcription factor: going with the flow, Hypertension, 67, 20–29.
Takabe, W., Warabi, E., and Noguchi, N. (2011) Antiatherogenic effect of laminar shear stress via Nrf2 activation, Antioxid. Redox Signal., 15, 1415–1426.
Turpaev, K. T. (2013) Keapl-Nrf2 signaling pathway: mechanisms of regulation and role in protection of cells against toxicity caused by xenobiotics and electrophiles, Biochemistry (Moscow), 78, 111–126.
Wardyn, J. D., Ponsford, A. H., and Sanderson, C. M. (2015) Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways, Biochem. Soc. Trans., 43, 621–626.
Kumar, A., Lin, Z., SenBanerjee, S., and Jain, M. K. (2005) Tumor necrosis factor alpha-mediated reduction of KLF2 is due to inhibition of MEF2 by NF-kappaB and histone deacetylases, Mol. Cell Biol., 25, 5893–5903.
Lee, H. Y., Youn, S. W., Cho, H. J., Kwon, Y. W., Lee, S. W., Kim, S. J., Park, Y. B., Oh, B. H., and Kim, H. S. (2013) FOXOl impairs whereas statin protects endothelial function in diabetes through reciprocal regulation of Kruppel-like factor 2, Cardiovasc. Res., 97, 143–152.
Kumar, A., Kim, C. S., Hoffman, T. A., Naqvi, A., Dericco, J., Jung, S. B., Lin, Z., Jain, M. K., and Irani, K. (2011) p53 impairs endothelial function by transcriptionally repressing Kruppel-like factor 2, Arterioscler. Thromb. Vase. Biol., 31, 133–141.
Wu, W., Xiao, H., Laguna-Fernandez, A., Villarreal, G., Wang, K. C., Geary, G. G., Zhang, Y., Wang, W. C., Huang, H. D., Zhou, J., Li, Y. S., Chien, S., Garcia-Cardena, G., and Shyy J. Y. (2011) Flow-dependent regulation of Kruppel-like factor 2 is mediated by microRNA-92a, Circulation, 124, 633–641.
Xin, Y., Zhang, H., Jia, Z., Ding, X., Sun, Y., Wang, Q., and Xu, T. (2018) Resveratrol improves uric acid-induced pancreatic P-cells injury and dysfunction through regulation of miR-126, Biomed. Pharmacother., 102, 1120–1126.
Manoharan, P., Basford, J. E., Pilcher-Roberts, R., Neumann, J., Hui, D. Y., and Lingrel, J. B. (2014) Reduced levels of microRNAs miR-124a and miR-150 are associated with increased proinflammatory mediator expression in Kruppel-like factor 2 (KLF2)-deficient macrophages, J. Biol. Chem., 289, 31638–31646.
Marin, T., Gongol, B., Chen, Z., Woo, B., Subramaniam, S., Chien, S., and Shyy, J. Y. (2013) Mechanosensitive microRNAs-role in endothelial responses to shear stress and redox state, Free Radic. Biol. Med., 64, 61–68.
Chu, U. B., Duellman, T., Weaver, S. J., Tao, Y., and Yang, J. (2015) Endothelial protective genes induced by statin are mimicked by ERK5 activation as triggered by a drug combination of FTI-277 and GGTI-298, Biochim. Biophys. Acta, 1850, 1415–1425.
Zhao, J., Natarajan, S. K., Chronos, N., and Singh, J. P. (2015) Cerivastatin represses atherogenic gene expression through the induction of KLF2 via isoprenoid metabolic pathways, Cell. Mol. Biol. Lett., 20, 825–839.
Jeong, A., Suazo, K. F., Wood, W. G., Distefano, M. D., and Li, L. (2018) Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer’s disease, Crit. Rev. Biochem. Mol. Biol., 53, 279–310.
Turpaev, K., Glatigny A., Bignon, J., Delacroix, H., and Drapier, J. C. (2010) Variation in gene expression profiles of human monocytic U937 cells exposed to various fluxes of nitric oxide, Free Radic. Biol. Med., 48, 298–305.
Xu, Q., Luan, T., Fu, S., Yang, J., Jiang, C., and Xia, F. (2014) Effects of pravastatin on the expression of VCAM-1 and its target gene miR-126 in cultured human umbilical vein endothelial cells, Cardiovasc. Ther., 32, 193–197.
Arefieva, T. I., Filatova, A. Y., Potekhina, A. V., and Shchinova, A. M. (2018) Immunotropic effects and proposed mechanism of action for 3-hydroxy-3-methylglu-taryl-coenzyme A reductase inhibitors (statins), Biochemistry (Moscow), 83, 874–889.
Davies, J. T., Delfino, S. E, Feinberg, C. E., Johnson, M. F, Nappi, V. L., Olinger, J. T., Schwab, A. P., and Swanson, H. I. (2016) Current and emerging uses of statins in clinical therapeutics: a review, Lipid Insights, 9, 13–29.
Ebert, R., Zeck, S., Meissner-Weigl, J., Klotz, B., Rachner, T. D., Benad, P., Klein-Hitpass, L., Rudert, M., Hofbauer, L. C., and Jakob, F (2012) Kruppel-like factors KLF2 and 6 and Ki-67 are direct targets of zoledronic acid in MCF-7 cells, Bone, 50, 723–732.
Rogers, M. J., Crockett, J. C., Coxon, F. P., and Monkkonen, J. (2011) Biochemical and molecular mechanisms of action of bisphosphonates, Bone, 49, 34–41.
Chu, H., Li, H., Guan, X., Yan, H., Zhang, X., Cui, X., Li, X., and Cheng, M. (2018) Resveratrol protects late endothelial progenitor cells from TNF-a-induced inflammatory damage by upregulating Kriippel-like factor-2, Mol. Med. Rep., 17, 5708–5715.
Bai, X., Yao, L., Ma, X., andXu, X. (2018) Small molecules as SIRT modulators, Mini Rev. Med. Chem., 18, 1151–1157.
Santos, J. C., Gotardo, E. M., Brianti, M. T., Piraee, M., Gambero, A., and Ribeiro, M. L. (2014) Effects of yerba mate, a plant extract formulation (đYGD”) and resveratrol in 3T3-L1 adipogenesis, Molecules, 19, 16909–16924.
Xu, Y., Liu, P., Xu, S., Koroleva, M., Zhang, S., Si, S., and Jin, Z. G. (2017) Tannic acid as a plant-derived polyphenol exerts vasoprotection via enhancing KLF2 expression in endothelial cells, Sci. Rep., 27, 6686.
Argari, D. P., Santos, J. C., Gambero, A., and Ribeiro, M. L. (2013) The in vitro and in vivo effects of yerba mate (Ilex paraguariensis) extract on adipogenesis, Food Chem., 141, 809–815.
Jeon, H. J., Choi, H. S., Lee, Y. J., Hwang, J. H., Lee, O. H., Seo, M. J., Kim, K. J., and Lee, B. Y. (2015) Seapolynol extracted from Ecklonia cava inhibits adipocyte differentiation in vitro and decreases fat accumulation in vivo, Molecules, 20, 21715–21731.
Lee, J. E., and Ge, K. (2014) Transcriptional and epigenet-ic regulation of PPARgamma expression during adipogenesis, Cell Biosci., 4, 29.
Kim, S. J., Xiao, J., Wan, J., Cohen, P., and Yen, K. (2017) Mitochondrially derived peptides as novel regulators of metabolism, J. Physiol., 595, 6613–6621.
Wang, X., Wu, Z., He, Y., Zhang, H., Tian, L., Zheng, C., Shang, T., Zhu, Q., Li, D., and He, Y. (2018) Humanin prevents high glucose-induced monocyte adhesion to endothelial cells by targeting KLF2, Mol. Immunol., 101, 245–250.
Wang, D., Song, Y., Zhang, J., Pang, W., Wang, X., Zhu, Y., and Li, X. (2017) AMPK-KLF2 signaling pathway mediates the proangiogenic effect of erythropoietin in endothelial colony-forming cells, Am. J. Physiol. Cell Physiol., 313, C674–C685.
Sako, K., Fukuhara, S., Minami, T., Hamakubo, T., Song, H., Kodama, T., Fukamizu, A., Gutkind, J. S., Koh, G. Y., and Mochizuki, N. (2009) Angiopoietin-1 induces Kruppel-like factor 2 expression through a phosphoinosi-tide 3-kinase/AKT-dependent activation of myocyte enhancer factor 2, J. Biol. Chem., 284, 5592–5601.
Turpaev, K. T. (2017) Genes and Cell Regulatory Systems Acting via NO-Linked Cascade and Thiol Group-Modified Receptors: Abstract of the doctoral dissertation [in Russian], Institute of Molecular Biology, Moscow.
Tian, R., Li, R., Liu, Y., Liu, J., Pan, T., Zhang, R., Liu, B., Chen, E., Tang, Y., and Qu, H. (2019) Metformin ameliorates endotoxemia-induced endothelial pro-inflammatory responses via AMPK-dependent mediation of HDAC5 and KLF2, Biochim. Biophys. Acta Mol. Basis Dis., 1865, 1701–1712.
Triggle, C. R., and Ding, H. (2016) Metformin is not just an antihyperglycemic drug but also has protective effects on the vascular endothelium, Acta Physiol. (Oxf.), 219, 138–151.
Chistiakov, D. A., Orekhov, A. N., and Bobryshev, Y. V. (2017) Treatment of cardiovascular pathology with epige-netically active agents: focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation, Int. J. Cardiol., III, 66–82.
Xu, Y., Xu, S., Liu, P., Koroleva, M., Zhang, S., Si, S., and Jin, Z. G. (2017) Suberanilohydroxamic acid as a pharmacological Kruppel-like factor 2 activator that represses vascular inflammation and atherosclerosis, J. Am. Heart Assoc, 6, e007134.
Das, M., Laha, D., Kanji, S., Joseph, M., Aggarwal, R., Iwenofu, O. H., Pompili, V. J., Jain, M. K., and Das, H. (2019) Induction of Kruppel-like factor 2 reduces K/BxN serum-induced arthritis, J. Cell. Mol. Med., 23, 1386–1395.
Hadden, M. J., and Advani, A. (2018) Histone deacetylase inhibitors and diabetic kidney disease, Int. J. Mol. Sci., 19, E2630.
Yoon, S., and Eom, G. H. (2016) HDAC and HDAC inhibitor: from cancer to cardiovascular diseases, Chonnam. Med. J., 52, 1–11.
Dekker, R. J., van Thienen, J. V., Rohlena, J., de Jager, S. C., Elderkamp, Y. W., Seppen, J., de Vries, C. J., Biessen, E. A., van Berkel, T. J., Pannekoek, H., and Horrevoets, A. J. (2005) Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes, Am. J. Pathol., 167, 609–618.
Das, M., Lu, J., Joseph, M., Aggarwal, R., Kanji, S., McMichael, B. K., Lee, B. S., Agarwal, S., Ray-Chaudhury A., Iwenofu, O. H., Kuppusamy P., Pompili, V. J., Jain, M. K., and Das, H. (2012) Kruppel-like factor 2 (KLF2) regulates monocyte differentiation and functions in mBSA and IL-ip-induced arthritis, Curr. Mol. Med., 12, 113–125.
Zhong, F., Lee, K., and He, J. C. (2018) Role of Kriippel-like factor-2 in kidney disease, Nephrology (Carlton), 13 (Suppl. 4), 53–56.
Wmkelmann, R., Sandrock, L., Kirberg, J., Jack, H. M., and Schuh, W. (2014) KLF2 - a negative regulator of pre -B cell clonal expansion and B cell activation, PloSOne, 29, e97953.
Nayak, L., Goduni, L., Takami, Y., Sharma, N., Kapil, P., Jain, M. K., and Mahabeleshwar, G. H. (2013) Kruppel-like factor 2 is a transcriptional regulator of chronic and acute inflammation, Am. J. Pathol., 182, 1696–1704.
Pabbisetty S. K., Rabacal, W., Volanakis, E. J., Parekh, V. V., Olivares-Villagomez, D., Cendron, D., Boyd, K. L., Van Kaer, L., and Sebzda, E. (2016) Peripheral tolerance can be modified by altering KLF2-regulated Treg migration, Proc. Natl. Acad. Sci. USA, 113, E4662-E4670.
Li, M., Wang, X., Fu, W., He, S., Li, D., and Ke, Q. (2011) CD4+CD25+Foxp3+ regulatory T cells protect endothelial function impaired by oxidized low density lipoprotein via the KLF-2 transcription factor, Cell. Physiol. Biochem., 28, 639–648.
Pabbisetty, S. K., Rabacal, W., Maseda, D., Cendron, D., Collins, P. L., Hoek, K. L., Parekh, V. V., Aune, T. M., and Sebzda, E. (2014) KLF2 is a rate-limiting transcription factor that can be targeted to enhance regulatory T-cell production, Proc. Natl. Acad. Sci. USA, 111, 9579–9584.
Pisanti, S., Picardi, P., Ciaglia, E., D’Alessandro, A., and Bifulco, M. (2014) Novel prospects of statins as therapeutic agents in cancer, Pharmacol. Res., 88, 84–98.
Fullerton, M. D. (2016) AMP-activated protein kinase and its multifaceted regulation of hepatic metabolism, Curr. Opin. lipidoi, 11, 172–180.
Marcelo, K. L., Means, A. R., and York, B. (2016) The Ca2+/calmodulin/CaMKK2 axis: Nature’s metabolic CaM shaft, Trends Endocrinol. Metab., 11, 706–718.
Author information
Authors and Affiliations
Corresponding author
Additional information
Funding
The study was conducted within the frame-work of the State Assignment no. AAAA-A18-118012390247-0.
Conflict of interest
The author declares no conflict of interest.
Compliance with ethical standards
Current review contains no description of experiments using human subjects or animals performed by the author.
Russian Text © The Author(s), 2020, published in Biokhimiya, 2020, Vol. 85, No. 1, pp. 64–79.
Rights and permissions
About this article
Cite this article
Turpaev, K.T. Transcription Factor KLF2 and Its Role in the Regulation of Inflammatory Processes. Biochemistry Moscow 85, 54–67 (2020). https://doi.org/10.1134/S0006297920010058
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297920010058